LegalView recently updated its peanut butter recall information portal with the latest details involving the salmonella poisonings that have led to the deaths of several consumers. A criminal probe has been developed to investigate the details surrounding the poisonings.
Denver, CO (PRWEB) February 5, 2009 -- LegalView.info, the number one legal resource available on the Internet, recently updated its peanut butter recall information portal with the latest news on the development of a criminal probe involving the salmonella poisonings and fatality of at least eight reported victims stemming from contaminated peanut butter from the Peanut Corp. of America, according to a Bloomberg news report. The U.S. Justice Department and the Food and Drug Administration (FDA) recently implemented the start of their investigation after reports that the Peanut Corp. of America surfaced detailing the companies awareness of peanut butter contamination prior to releasing their product for public consumption, as reported by the Bloomberg news agency on Jan. 30.
Individuals who have suffered as a result of the peanut butter recall are advised to speak with an experienced peanut butter recall lawyer regarding the details of a potential peanut butter recall lawsuit. This may be a necessary step in preventing further harm to individuals who have yet to be infected with the salmonella poisonings as well as any of the 529 individuals who have been victims of the peanut butter recall. A legal consultation is often free and can sometimes lead to the retrieval of monetary compensation for any of the unintended harm that may have befell peanut butter recall victims. To learn more, visit http://peanut-butter.legalview.info/.
In addition to offering the latest and most newsworthy information to victims of the peanut butter recall, LegalView also offers an extensive library of legal topics ranging from the latest mesothelioma treatments to news on Fosamax and the Stryker Custom Cranial Kit recall.
Mesothelioma is a deadly form of lung cancer that has been linked to the inhalation of asbestos fibers and asbestos dust. Following initial inhalation of the asbestos, a victim may be unaware of the cancerous cells beginning to form on the inside of their lungs and other internal organs. Quite frequently the victim will be unaware of their condition for years, possibly decades as mesothelioma symptoms usually remain dormant anywhere from 10 to 40 years. However, upon a mesothelioma diagnosis, a victim is encouraged to meet with a mesothelioma lawyer to better assess their potential for developing litigation that may result in monetary compensation.
Fosamax, which is used to treat bone density loss among osteoporosis patients including menopausal women, was recently criticized for its apparent Fosamax side effects, which not only include the potential onset of jaw bone die off, but has also been linked to the development of at least 23 cases of esophageal cancer, as reported in the January issues of The New England Journal of Medicine and the Journal of the American Dental Association.
The Stryker Custom Cranial Kit recall recently occurred and was reported in a U.S. Food and Drug Administration (FDA) public health advisory from January, setting off tensions among the 300 plus individuals who may have been affected by the cranial implant recall and who may also be at risk for severe side effects and even death following the recall, which occurred after sterility issues arose from the kits.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.info.
Read the full story at http://www.prweb.com/releases/2009/02/prweb1946904.htm.
Copyright©2009 Vocus, Inc.
All rights reserved